» Articles » PMID: 22853951

Peptidylarginine Deiminase 2-catalyzed Histone H3 Arginine 26 Citrullination Facilitates Estrogen Receptor α Target Gene Activation

Abstract

Cofactors for estrogen receptor α (ERα) can modulate gene activity by posttranslationally modifying histone tails at target promoters. Here, we found that stimulation of ERα-positive cells with 17β-estradiol (E2) promotes global citrullination of histone H3 arginine 26 (H3R26) on chromatin. Additionally, we found that the H3 citrulline 26 (H3Cit26) modification colocalizes with ERα at decondensed chromatin loci surrounding the estrogen-response elements of target promoters. Surprisingly, we also found that citrullination of H3R26 is catalyzed by peptidylarginine deiminase (PAD) 2 and not by PAD4 (which citrullinates H4R3). Further, we showed that PAD2 interacts with ERα after E2 stimulation and that inhibition of either PAD2 or ERα strongly suppresses E2-induced H3R26 citrullination and ERα recruitment at target gene promoters. Collectively, our data suggest that E2 stimulation induces the recruitment of PAD2 to target promoters by ERα, whereby PAD2 then citrullinates H3R26, which leads to local chromatin decondensation and transcriptional activation.

Citing Articles

Identification of novel PAD2 inhibitors using pharmacophore-based virtual screening, molecular docking, and MD simulation studies.

Jha P, Rajoria P, Poonia P, Chopra M Sci Rep. 2024; 14(1):28097.

PMID: 39543332 PMC: 11564549. DOI: 10.1038/s41598-024-78330-5.


Unexpected nuclear hormone receptor and chromatin dynamics regulate estrous cycle dependent gene expression.

Jefferson W, Wang T, Padilla-Banks E, Williams C Nucleic Acids Res. 2024; 52(18):10897-10917.

PMID: 39166489 PMC: 11472041. DOI: 10.1093/nar/gkae714.


Evolutionary analysis reveals the role of a non-catalytic domain of peptidyl arginine deiminase 2 in transcriptional regulation.

Villanueva-Canas J, Fernandez-Fuentes N, Saul D, Kosinsky R, Teyssier C, Rogalska M iScience. 2024; 27(4):109584.

PMID: 38623337 PMC: 11016909. DOI: 10.1016/j.isci.2024.109584.


Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.

Wang Y, Song X, Song Y, Fang K, Chang X J Cancer Res Clin Oncol. 2023; 149(19):17253-17268.

PMID: 37804426 PMC: 10657297. DOI: 10.1007/s00432-023-05433-3.


Peptidylarginine deiminase 4 and ADAMTS13 activity in bacteraemia.

Martens C, Peetermans M, Vanassche T, Verhamme P, Jacquemin M, Martinod K Philos Trans R Soc Lond B Biol Sci. 2023; 378(1890):20230042.

PMID: 37778390 PMC: 10542450. DOI: 10.1098/rstb.2023.0042.


References
1.
Sharp Z, Mancini M, Hinojos C, Dai F, Berno V, Szafran A . Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. J Cell Sci. 2006; 119(Pt 19):4101-16. DOI: 10.1242/jcs.03161. View

2.
Cuthbert G, Daujat S, Snowden A, Erdjument-Bromage H, Hagiwara T, Yamada M . Histone deimination antagonizes arginine methylation. Cell. 2004; 118(5):545-53. DOI: 10.1016/j.cell.2004.08.020. View

3.
Welboren W, van Driel M, Janssen-Megens E, van Heeringen S, Sweep F, Span P . ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009; 28(10):1418-28. PMC: 2688537. DOI: 10.1038/emboj.2009.88. View

4.
Krishnakumar R, Kraus W . PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell. 2010; 39(5):736-49. PMC: 2939044. DOI: 10.1016/j.molcel.2010.08.014. View

5.
Vic P, Garcia M, Humeau C, ROCHEFORT H . Early effect of estrogen on chromatin ultrastructure in endometrial nuclei. Mol Cell Endocrinol. 1980; 19(1):79-92. DOI: 10.1016/0303-7207(80)90032-5. View